Explore our solutions
Clone selection & development
Clone generation from either hybridoma, phage display or from B cell generates thousands of potential leads. These leads require screening, usually done with an ELISA based Protein-Protein Interaction, to identify a primary selection of optimal leads. Once optimal leads are identified, follow-up screening is performed in various functional assays to determine the biologic candidate’s therapeutic potential.
Helping you discover biologics binders with our CHOSOURCE expression platform, multiple chemistries for high throughput antigen-protein elucidation, and integrated automation solutions, all designed to help save you time and move you along your lead discovery workflow.
Suggested links :
CHOSOURCE Platform
The CHOSOURCE™ expression platform enables rapid generation of clones expressing high levels of recombinant therapeutic protein during stable cell line development.
Immunoassays
Since their introduction in the 1950’s, immunoassays have been an integral part of research and drug discovery.
Protein-protein interaction research reagents
The interactions and binding of proteins are implicated in a large number of biological processes. The need for efficient, highly sensitive assays to study large protein interactions is increasingly important.
Biomolecular target ID and validation
Let us help you along the path towards a lead by providing access to our integrated solutions for target identification and validation.
Offering molecular characterization assays and reagents, cellular and in vivo imaging technologies, physiologically relevant and predictive model systems, automated liquid handling, detection systems, and data analytics software, to help enable identification and validation of targets to streamline your drug discovery workflow.
Suggested links :
Cell Counting and Image Cytometry
Revvity offers a leading portfolio of automated cell counters, image cytometry systems, and cell counting reagents and consumables.
Immunoassays
Since their introduction in the 1950’s, immunoassays have been an integral part of research and drug discovery.
Automated Liquid Handling
We've been providing liquid handling solutions for over 40 years to help labs accelerate their science.
High Content Screening Instruments
High-Content Analysis (HCA) or High-Content Screening (HCS) combines high-throughput automated imaging and analysis to extract quantitative multi-parametric data at the single-cell level.
Microfluidic Analysis
If you need to analyse proteins, nucleic acids, or both, Revvity’s automated microfluidic capillary electrophoresis (micro-CE) technology enables the simplification
Microplate Readers
As many of you know, microplate readers are instruments used to detect biological, chemical, biochemical or physical events from samples in a microplate.
Revvity Signals
Bring every discipline, from small molecules to large modalities, together. Signals is the cloud software suite that eliminates data
Lead discovery and screening
Labs that efficiently identify key drug discovery parameters can quickly promote the most appropriate targets and develop medicines to affect them. Our screening and lead-discovery solutions let you manage screening data from raw imports, QC, analytics, and visualizations – and publish and share that data, too.
Suggested links :
Phenotypic Screening
HCS assays are at the heart of phenotypic drug discovery – a strategy which implies little foreknowledge of the mode-of-action of...
Complex Cell Model Screening Services
Traditional 2D cell models fail to capture the complexity of human biology in today’s dynamic research environment.
Cell Panel Screening
Identify cells that respond to therapeutics by screening over 300 standard cancer cell lines in 2D or 3D formats using OncoSignature screening services